Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864.SZ
36.39 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 261.566 | 245.241 | 210.116 | 264.595 | 216.214 | 274.393 | 225.625 | 280.845 | 262.473 | 232.146 | 198.829 | 264.836 | 221.139 | 226.641 | 174.868 | 219.016 | 213.597 | 156.513 | 81.187 | 174.832 | 152.542 | 162.728 | 120.534 | 150.916 | 130.192 | 114.093 | 94.247 | 103.571 | 111.874 | 94.775 | 66.572 | 95.842 | 76.305 | 66.639 | 66.639 |
Cost of Revenue
| 103.02 | 91.077 | 79.96 | 113.438 | 73.42 | 111.644 | 114.244 | 117.748 | 101.651 | 102.979 | 85.632 | 124.925 | 83.238 | 92.158 | 69.952 | 87.188 | 81.099 | 55.116 | 29.353 | 56.5 | 45.833 | 46.564 | 37.362 | 43.253 | 37.303 | 30.757 | 29.9 | 32.642 | 33.26 | 29.568 | 20.464 | 36.824 | 24.582 | 25.802 | 25.802 |
Gross Profit
| 158.547 | 154.164 | 130.155 | 151.158 | 142.794 | 162.749 | 111.381 | 163.098 | 160.822 | 129.168 | 113.197 | 139.911 | 137.902 | 134.483 | 104.917 | 131.828 | 132.497 | 101.397 | 51.834 | 118.332 | 106.709 | 116.164 | 83.173 | 107.663 | 92.889 | 83.336 | 64.347 | 70.929 | 78.613 | 65.207 | 46.108 | 59.018 | 51.724 | 40.837 | 40.837 |
Gross Profit Ratio
| 0.606 | 0.629 | 0.619 | 0.571 | 0.66 | 0.593 | 0.494 | 0.581 | 0.613 | 0.556 | 0.569 | 0.528 | 0.624 | 0.593 | 0.6 | 0.602 | 0.62 | 0.648 | 0.638 | 0.677 | 0.7 | 0.714 | 0.69 | 0.713 | 0.713 | 0.73 | 0.683 | 0.685 | 0.703 | 0.688 | 0.693 | 0.616 | 0.678 | 0.613 | 0.613 |
Reseach & Development Expenses
| 9.59 | 10.538 | 3.718 | 4.515 | 5.122 | 7.339 | 3.28 | 9.076 | 5.038 | 2.079 | 2.041 | 8.113 | 2.554 | 1.709 | 1.651 | 8.328 | 1.319 | 2.058 | 1.266 | 7.798 | 1.937 | 1.624 | 1.718 | 2.62 | 3.616 | 1.235 | 0.82 | 3.285 | 2.173 | 2.746 | 0 | 5.415 | 2.591 | 1.295 | 1.295 |
General & Administrative Expenses
| 35.964 | -0.645 | 12.693 | -21.998 | 31.773 | -2.871 | 12.194 | -19.551 | 29.823 | -3.552 | 9.601 | -20.547 | 28.215 | -0.206 | 9.166 | -11.713 | 10.971 | -1.577 | 5.9 | -12.937 | 8.97 | -3.778 | 8.496 | -11.234 | 7.518 | -0.245 | 8.828 | -13.303 | 5.322 | -3.769 | 6.757 | -12.55 | 7.387 | 5.883 | 5.883 |
Selling & Marketing Expenses
| 118.433 | 94.618 | 87.562 | 94.023 | 92.076 | 102.774 | 72.224 | 105.791 | 99.832 | 81.227 | 75.892 | 92.604 | 86.422 | 86.531 | 67.64 | 87.627 | 77.028 | 64.446 | 33.734 | 77.882 | 72.517 | 72.768 | 58.198 | 74.034 | 63.186 | 57.089 | 43.58 | 46.3 | 52.511 | 41.616 | 29.252 | 35.408 | 31.402 | 26.452 | 26.452 |
SG&A
| 154.397 | 93.973 | 100.255 | 72.025 | 123.849 | 99.903 | 84.418 | 86.24 | 129.655 | 77.674 | 85.494 | 72.057 | 114.637 | 86.325 | 76.806 | 75.914 | 87.999 | 62.869 | 39.633 | 64.945 | 81.487 | 68.99 | 66.694 | 62.8 | 70.703 | 56.844 | 52.408 | 32.997 | 57.833 | 37.846 | 36.009 | 22.859 | 38.789 | 32.699 | 32.699 |
Other Expenses
| -33.552 | -0.134 | 4.975 | -5.267 | -0.487 | 0.015 | 0.477 | 39.946 | -13.632 | 16.717 | 1.232 | -8.086 | 3.27 | -3.088 | -3.668 | -0.831 | -0.197 | 2.035 | -1.488 | 0.619 | -0.073 | -2.623 | -0.727 | -0.748 | 1.387 | 7.492 | -0.493 | -1.033 | -0.062 | -0.342 | -0.024 | 2.181 | -1.036 | 0 | 0 |
Operating Expenses
| 130.435 | 123.974 | 104.292 | 118.785 | 110.38 | 125.436 | 88.175 | 135.261 | 121.061 | 96.47 | 88.767 | 118.716 | 103.804 | 104.513 | 80.111 | 112.818 | 91.402 | 77.341 | 41.39 | 102.842 | 85.093 | 85.173 | 70.063 | 89.531 | 76.467 | 70.622 | 53.644 | 60.384 | 61.899 | 51.533 | 37.004 | 41.772 | 39.7 | 32.881 | 32.881 |
Operating Income
| 35.208 | 32.166 | 30.662 | 36.874 | 34.929 | 38.016 | 25.04 | 25.854 | 39.944 | 30.934 | 26.29 | 22.192 | 36.823 | 28.006 | 25.504 | 16.59 | 41.07 | 24.388 | 12.929 | 15.995 | 23.074 | 32.612 | 14.673 | 22.043 | 17.476 | 16.375 | 11.787 | 10.726 | 18.332 | 13.091 | 8.268 | 16.971 | 12.521 | 7.397 | 7.397 |
Operating Income Ratio
| 0.135 | 0.131 | 0.146 | 0.139 | 0.162 | 0.139 | 0.111 | 0.092 | 0.152 | 0.133 | 0.132 | 0.084 | 0.167 | 0.124 | 0.146 | 0.076 | 0.192 | 0.156 | 0.159 | 0.091 | 0.151 | 0.2 | 0.122 | 0.146 | 0.134 | 0.144 | 0.125 | 0.104 | 0.164 | 0.138 | 0.124 | 0.177 | 0.164 | 0.111 | 0.111 |
Total Other Income Expenses Net
| -1.3 | -0.134 | 4.975 | -5.267 | -0.487 | 0.015 | 0.128 | 0.137 | 0.064 | -1.245 | -2.798 | -0.01 | 2.862 | -1.918 | -2.969 | -3.251 | -0.222 | 2.367 | 0.998 | 1.124 | 1.386 | -1.002 | 0.836 | 3.163 | 2.441 | 11.153 | 0.592 | 0.178 | 1.555 | -0.891 | -0.86 | 1.547 | -0.532 | 0.55 | 0.55 |
Income Before Tax
| 33.908 | 32.032 | 35.637 | 31.607 | 34.443 | 38.032 | 25.168 | 25.991 | 40.009 | 29.689 | 23.492 | 22.182 | 36.96 | 28.051 | 21.836 | 15.76 | 40.873 | 26.423 | 11.441 | 16.615 | 23.001 | 29.989 | 13.945 | 21.295 | 18.863 | 23.867 | 11.294 | 10.723 | 18.269 | 12.782 | 8.244 | 18.794 | 11.492 | 7.948 | 7.948 |
Income Before Tax Ratio
| 0.13 | 0.131 | 0.17 | 0.119 | 0.159 | 0.139 | 0.112 | 0.093 | 0.152 | 0.128 | 0.118 | 0.084 | 0.167 | 0.124 | 0.125 | 0.072 | 0.191 | 0.169 | 0.141 | 0.095 | 0.151 | 0.184 | 0.116 | 0.141 | 0.145 | 0.209 | 0.12 | 0.104 | 0.163 | 0.135 | 0.124 | 0.196 | 0.151 | 0.119 | 0.119 |
Income Tax Expense
| 4.06 | 3.654 | 4.579 | 4.577 | 4.798 | 4.973 | 3.355 | 2.785 | 5.69 | 4.378 | 3.18 | 2.244 | 5.237 | 3.561 | 3.43 | 1.615 | 6.551 | 3.637 | 1.602 | 2.889 | 2.676 | 4.248 | 1.959 | 2.876 | 2.599 | 3.481 | 1.681 | 0.097 | 2.712 | 2.136 | 1.354 | 2.476 | 1.691 | 1.217 | 1.217 |
Net Income
| 29.918 | 28.506 | 31.147 | 26.329 | 29.849 | 32.693 | 21.562 | 23.195 | 33.099 | 24.788 | 20.082 | 20.062 | 30.686 | 24.682 | 17.739 | 13.097 | 33.573 | 22.606 | 9.839 | 13.725 | 20.326 | 25.741 | 11.987 | 18.419 | 16.264 | 20.386 | 9.613 | 10.626 | 15.557 | 10.646 | 6.89 | 16.295 | 9.808 | 6.712 | 6.712 |
Net Income Ratio
| 0.114 | 0.116 | 0.148 | 0.1 | 0.138 | 0.119 | 0.096 | 0.083 | 0.126 | 0.107 | 0.101 | 0.076 | 0.139 | 0.109 | 0.101 | 0.06 | 0.157 | 0.144 | 0.121 | 0.079 | 0.133 | 0.158 | 0.099 | 0.122 | 0.125 | 0.179 | 0.102 | 0.103 | 0.139 | 0.112 | 0.103 | 0.17 | 0.129 | 0.101 | 0.101 |
EPS
| 0.29 | 0.28 | 0.3 | 0.57 | 0.28 | 0.34 | 0.23 | 0.27 | 0.39 | 0.29 | 0.23 | 0.23 | 0.36 | 0.29 | 0.21 | 0.15 | 0.39 | 0.26 | 0.11 | 0.16 | 0.23 | 0.3 | 0.14 | 0.21 | 0.19 | 0.23 | 0.11 | 0.16 | 0.24 | 0.17 | 0.11 | 0.26 | 0.16 | 0.11 | 0.11 |
EPS Diluted
| 0.29 | 0.28 | 0.3 | 0.55 | 0.28 | 0.34 | 0.23 | 0.27 | 0.38 | 0.28 | 0.23 | 0.23 | 0.36 | 0.29 | 0.21 | 0.15 | 0.39 | 0.26 | 0.11 | 0.16 | 0.23 | 0.3 | 0.14 | 0.21 | 0.19 | 0.23 | 0.11 | 0.16 | 0.24 | 0.17 | 0.11 | 0.26 | 0.16 | 0.11 | 0.11 |
EBITDA
| 34.836 | 36.132 | 38.786 | 32.583 | 36.121 | 42.14 | 29.24 | 32.742 | 44.316 | 36.013 | 24.74 | 24.178 | 37.277 | 32.861 | 23.826 | 20.433 | 43.202 | 28.865 | 9.791 | 17.019 | 22.463 | 32.013 | 13.837 | 35.534 | 17.849 | 24.919 | 11.677 | 11.839 | 15.254 | 12.898 | 9.937 | 20.164 | 11.288 | 8.41 | 8.41 |
EBITDA Ratio
| 0.133 | 0.147 | 0.185 | 0.123 | 0.167 | 0.154 | 0.13 | 0.117 | 0.169 | 0.155 | 0.124 | 0.091 | 0.169 | 0.145 | 0.136 | 0.093 | 0.202 | 0.184 | 0.121 | 0.097 | 0.147 | 0.197 | 0.115 | 0.235 | 0.137 | 0.218 | 0.124 | 0.114 | 0.136 | 0.136 | 0.149 | 0.21 | 0.148 | 0.126 | 0.126 |